$WST
WEST PHARMACEUTICAL SERVICES INC

2019 Q1 Form 10-Q Financial Statement

#000010577019000020 Filed on May 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q1
Revenue $443.5M $415.7M
YoY Change 6.69% 7.22%
Cost Of Revenue $296.7M $281.3M
YoY Change 5.47% 10.97%
Gross Profit $146.8M $134.4M
YoY Change 9.23% 0.15%
Gross Profit Margin 33.1% 32.33%
Selling, General & Admin $68.60M $68.30M
YoY Change 0.44% 9.28%
% of Gross Profit 46.73% 50.82%
Research & Development $9.800M $9.600M
YoY Change 2.08% -6.8%
% of Gross Profit 6.68% 7.14%
Depreciation & Amortization $24.90M $25.70M
YoY Change -3.11% 13.72%
% of Gross Profit 16.96% 19.12%
Operating Expenses $78.40M $77.90M
YoY Change 0.64% 7.01%
Operating Profit $70.70M $53.40M
YoY Change 32.4% -11.74%
Interest Expense $2.300M $1.900M
YoY Change 21.05% -9.52%
% of Operating Profit 3.25% 3.56%
Other Income/Expense, Net -$600.0K $1.600M
YoY Change -137.5% 100.0%
Pretax Income $69.90M $53.70M
YoY Change 30.17% -9.75%
Income Tax $16.10M $12.50M
% Of Pretax Income 23.03% 23.28%
Net Earnings $55.40M $43.60M
YoY Change 27.06% -28.41%
Net Earnings / Revenue 12.49% 10.49%
Basic Earnings Per Share $0.75 $0.59
Diluted Earnings Per Share $0.73 $0.58
COMMON SHARES
Basic Shares Outstanding 74.10M shares 73.90M shares
Diluted Shares Outstanding 75.30M shares 75.50M shares

Balance Sheet

Concept 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $265.5M $199.8M
YoY Change 32.88% 17.95%
Cash & Equivalents $265.5M $199.8M
Short-Term Investments
Other Short-Term Assets $57.80M $30.80M
YoY Change 87.66% -33.19%
Inventory $226.1M $194.4M
Prepaid Expenses
Receivables $318.2M $278.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $867.6M $743.5M
YoY Change 16.69% 13.93%
LONG-TERM ASSETS
Property, Plant & Equipment $814.7M $857.8M
YoY Change -5.02% 9.58%
Goodwill $105.2M $108.8M
YoY Change -3.31% 5.12%
Intangibles $19.50M $22.80M
YoY Change -14.47% -1.3%
Long-Term Investments $81.50M $76.50M
YoY Change 6.54% 12.67%
Other Assets $26.40M $21.90M
YoY Change 20.55% 1.86%
Total Long-Term Assets $1.169B $1.126B
YoY Change 3.77% 4.18%
TOTAL ASSETS
Total Short-Term Assets $867.6M $743.5M
Total Long-Term Assets $1.169B $1.126B
Total Assets $2.036B $1.870B
YoY Change 8.91% 7.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $137.7M $127.6M
YoY Change 7.92% 20.26%
Accrued Expenses $65.90M $52.90M
YoY Change 24.57% 14.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $301.1M $263.4M
YoY Change 14.31% 2.69%
LONG-TERM LIABILITIES
Long-Term Debt $195.5M $198.0M
YoY Change -1.26% 1.96%
Other Long-Term Liabilities $34.10M $37.70M
YoY Change -9.55% -20.3%
Total Long-Term Liabilities $229.6M $235.7M
YoY Change -2.59% -2.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $301.1M $263.4M
Total Long-Term Liabilities $229.6M $235.7M
Total Liabilities $666.7M $564.3M
YoY Change 18.15% -0.11%
SHAREHOLDERS EQUITY
Retained Earnings $1.398B $1.190B
YoY Change 17.54% 6.33%
Common Stock $18.80M $18.80M
YoY Change 0.0% 1.08%
Preferred Stock
YoY Change
Treasury Stock (at cost) $172.6M $149.0M
YoY Change 15.84% 126.44%
Treasury Stock Shares 1.800M shares 1.700M shares
Shareholders Equity $1.370B $1.305B
YoY Change
Total Liabilities & Shareholders Equity $2.036B $1.870B
YoY Change 8.91% 7.85%

Cashflow Statement

Concept 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income $55.40M $43.60M
YoY Change 27.06% -28.41%
Depreciation, Depletion And Amortization $24.90M $25.70M
YoY Change -3.11% 13.72%
Cash From Operating Activities $47.60M $45.00M
YoY Change 5.78% 117.39%
INVESTING ACTIVITIES
Capital Expenditures $28.80M $28.00M
YoY Change 2.86% -25.33%
Acquisitions
YoY Change
Other Investing Activities -$100.0K $700.0K
YoY Change -114.29% -125.0%
Cash From Investing Activities -$28.70M -$28.70M
YoY Change 0.0% -17.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $83.10M $47.90M
YoY Change 73.49% 78.07%
Debt Paid & Issued, Net $0.00
YoY Change
Cash From Financing Activities -$90.50M -$56.90M
YoY Change 59.05% 161.01%
NET CHANGE
Cash From Operating Activities $47.60M $45.00M
Cash From Investing Activities -$28.70M -$28.70M
Cash From Financing Activities -$90.50M -$56.90M
Net Change In Cash -$71.90M -$40.60M
YoY Change 77.09% 13.41%
FREE CASH FLOW
Cash From Operating Activities $47.60M $45.00M
Capital Expenditures $28.80M $28.00M
Free Cash Flow $18.80M $17.00M
YoY Change 10.59% -201.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 dei Amendment Flag
AmendmentFlag
false
CY2019Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2019Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019Q1 dei Document Period End Date
DocumentPeriodEndDate
2019-03-31
CY2019Q1 dei Document Type
DocumentType
10-Q
CY2019Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000105770
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
73483687 shares
CY2019Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2019Q1 dei Entity Registrant Name
EntityRegistrantName
WEST PHARMACEUTICAL SERVICES INC
CY2019Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
130400000 USD
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
137700000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
288200000 USD
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
318200000 USD
CY2018Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
9800000 USD
CY2019Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
17300000 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
930700000 USD
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
945200000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-154200000 USD
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-153400000 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
282000000 USD
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
278500000 USD
CY2018Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
700000 USD
CY2019Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
600000 USD
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3400000 USD
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6200000 USD
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000 shares
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000 shares
CY2018Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
100000 USD
CY2019Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2018Q4 us-gaap Assets
Assets
1978900000 USD
CY2019Q1 us-gaap Assets
Assets
2036200000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
894400000 USD
CY2019Q1 us-gaap Assets Current
AssetsCurrent
867600000 USD
CY2018Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
15200000 USD
CY2019Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
27100000 USD
CY2018Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
300000 USD
CY2019Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
200000 USD
CY2018Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1700000 USD
CY2019Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1700000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
235900000 USD
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
199800000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
337400000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
265500000 USD
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-36100000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-71900000 USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.25
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.25
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75300000 shares
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75300000 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74100000 shares
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73500000 shares
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
18800000 USD
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
18800000 USD
CY2018Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
65100000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
56200000 USD
CY2018Q1 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.00
CY2019Q1 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.00
CY2018Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
9100000 USD
CY2019Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
11900000 USD
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
33400000 USD
CY2019Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
36500000 USD
CY2019Q1 us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
-3100000 USD
CY2019Q1 us-gaap Contract With Customer Liability Explanation Of Change
ContractWithCustomerLiabilityExplanationOfChange
1.7
CY2019Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
11100000 USD
CY2019Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
25800000 USD
CY2019Q1 us-gaap Contract With Customer Timing Of Satisfaction Of Performance Obligation And Payment
ContractWithCustomerTimingOfSatisfactionOfPerformanceObligationAndPayment
30.6
CY2018Q4 us-gaap Cost Method Investments
CostMethodInvestments
13400000 USD
CY2019Q1 us-gaap Cost Method Investments
CostMethodInvestments
13400000 USD
CY2018Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
281300000 USD
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
296700000 USD
CY2018Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
11400000 USD
CY2018Q4 us-gaap Debt Current
DebtCurrent
100000 USD
CY2019Q1 us-gaap Debt Current
DebtCurrent
0 USD
CY2018Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
196700000 USD
CY2019Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
196100000 USD
CY2018Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
9800000 USD
CY2019Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
10500000 USD
CY2018Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
8700000 USD
CY2019Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
9200000 USD
CY2018Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
24700000 USD
CY2019Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
32700000 USD
CY2018Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
13100000 USD
CY2019Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
14300000 USD
CY2018Q1 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-400000 USD
CY2019Q1 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
0 USD
CY2018Q1 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
-500000 USD
CY2019Q1 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
-200000 USD
CY2018Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
3900000 USD
CY2019Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
2900000 USD
CY2018Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
2400000 USD
CY2019Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
2500000 USD
CY2018Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1200000 USD
CY2019Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-200000 USD
CY2018Q1 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
2800000 USD
CY2019Q1 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
400000 USD
CY2018Q1 us-gaap Depreciation
Depreciation
25700000 USD
CY2019Q1 us-gaap Depreciation
Depreciation
24900000 USD
CY2018Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10400000 USD
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10600000 USD
CY2018Q4 us-gaap Due From Affiliates
DueFromAffiliates
1600000 USD
CY2019Q1 us-gaap Due From Affiliates
DueFromAffiliates
1400000 USD
CY2018Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
12900000 USD
CY2019Q1 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
17200000 USD
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
CY2018Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
4500000 USD
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-300000 USD
CY2018Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.233
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.231
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
64500000 USD
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
53500000 USD
CY2018Q4 us-gaap Equity Method Investments
EquityMethodInvestments
77800000 USD
CY2019Q1 us-gaap Equity Method Investments
EquityMethodInvestments
81500000 USD
CY2018 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-2600000 USD
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
200000 USD
CY2018 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
600000 USD
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
200000 USD
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4900000 USD
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1700000 USD
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1700000 USD
CY2018Q4 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
6500000 USD
CY2019Q1 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
17700000 USD
CY2018Q4 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
200000 USD
CY2019Q1 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
800000 USD
CY2018Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
400000 USD
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3800000 USD
CY2019Q1 us-gaap Gain Loss On Foreign Currency Fair Value Hedge Derivatives
GainLossOnForeignCurrencyFairValueHedgeDerivatives
4800000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
105800000 USD
CY2019Q1 us-gaap Goodwill
Goodwill
105200000 USD
CY2018Q1 us-gaap Gross Profit
GrossProfit
134400000 USD
CY2019Q1 us-gaap Gross Profit
GrossProfit
146800000 USD
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
53700000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
69900000 USD
CY2018Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2400000 USD
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1600000 USD
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12500000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16100000 USD
CY2018Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
2700000 USD
CY2019Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
800000 USD
CY2018Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1600000 shares
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1200000 shares
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20300000 USD
CY2019Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19500000 USD
CY2018Q1 us-gaap Interest Expense
InterestExpense
1900000 USD
CY2019Q1 us-gaap Interest Expense
InterestExpense
2300000 USD
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
81900000 USD
CY2019Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
87000000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
214500000 USD
CY2019Q1 us-gaap Inventory Net
InventoryNet
226100000 USD
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
90400000 USD
CY2019Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
100100000 USD
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
42200000 USD
CY2019Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
39000000 USD
CY2018Q1 us-gaap Investment Income Net
InvestmentIncomeNet
600000 USD
CY2019Q1 us-gaap Investment Income Net
InvestmentIncomeNet
900000 USD
CY2018Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
91200000 USD
CY2019Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
94900000 USD
CY2018Q1 us-gaap Lease Cost
LeaseCost
3700000 USD
CY2019Q1 us-gaap Lease Cost
LeaseCost
4000000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
95600000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
49000000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
7600000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
8100000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
9800000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
11500000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
9600000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
18000000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
582600000 USD
CY2019Q1 us-gaap Liabilities
Liabilities
666700000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1978900000 USD
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2036200000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
283700000 USD
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
301100000 USD
CY2018Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
11700000 USD
CY2019Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
13000000 USD
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
196100000 USD
CY2019Q1 us-gaap Long Term Debt
LongTermDebt
195500000 USD
CY2018Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
192600000 USD
CY2019Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
197400000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
196000000 USD
CY2019Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
195500000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-56900000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-90500000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28700000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28700000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
45000000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
47600000 USD
CY2019Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
53400000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
70700000 USD
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
3200000 USD
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
77600000 USD
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 USD
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10200000 USD
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
67400000 USD
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
3100000 USD
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 USD
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
75200000 USD
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0374
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y1M5D
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
81500000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
13000000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
5500000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
6900000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
7800000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
10500000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
37800000 USD
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
54300000 USD
CY2019Q1 us-gaap Other Assets Current
OtherAssetsCurrent
57800000 USD
CY2019Q1 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
200000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20500000 USD
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26400000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
1200000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
2200000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-3300000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
800000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
1600000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
20000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4400000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
21500000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
800000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
700000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
300000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-300000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
0 USD
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
76600000 USD
CY2019Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
80200000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
33600000 USD
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
34100000 USD
CY2018Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
25600000 USD
CY2019Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
38800000 USD
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1600000 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
600000 USD
CY2018Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
300000 USD
CY2019Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2900000 USD
CY2018Q1 us-gaap Other Restructuring Costs
OtherRestructuringCosts
1200000 USD
CY2019Q1 us-gaap Other Restructuring Costs
OtherRestructuringCosts
300000 USD
CY2018Q1 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
200000 USD
CY2019Q1 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
200000 USD
CY2018Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
700000 USD
CY2019Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-100000 USD
CY2018Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
47900000 USD
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
83100000 USD
CY2018Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2019Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
800000 USD
CY2018Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10400000 USD
CY2019Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
11100000 USD
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28000000 USD
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28800000 USD
CY2018Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
2300000 USD
CY2019Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
2200000 USD
CY2018Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
56200000 USD
CY2019Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
54300000 USD
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1100000 USD
CY2019Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1200000 USD
CY2018Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 USD
CY2019Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
28000000 USD
CY2018Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
300000 USD
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3300000 USD
CY2018Q1 us-gaap Profit Loss
ProfitLoss
43600000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
55400000 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1752700000 USD
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1759900000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
822000000 USD
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
814700000 USD
CY2019Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
400000 USD
CY2018Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 USD
CY2019Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
28000000 USD
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9600000 USD
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9800000 USD
CY2018Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
3300000 USD
CY2019Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
600000 USD
CY2018Q1 us-gaap Restructuring Charges
RestructuringCharges
3300000 USD
CY2019Q1 us-gaap Restructuring Charges
RestructuringCharges
600000 USD
CY2018Q1 us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
100000 USD
CY2018Q1 us-gaap Revenues
Revenues
415700000 USD
CY2019Q1 us-gaap Revenues
Revenues
443500000 USD
CY2019Q1 us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
300000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1353400000 USD
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1398200000 USD
CY2018 us-gaap Revenue Recognition Sales Returns Reserve For Sales Returns
RevenueRecognitionSalesReturnsReserveForSalesReturns
11300000 USD
CY2019Q1 us-gaap Revenue Recognition Sales Returns Reserve For Sales Returns
RevenueRecognitionSalesReturnsReserveForSalesReturns
4500000 USD
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6800000 USD
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
68300000 USD
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
68600000 USD
CY2018Q1 us-gaap Severance Costs1
SeveranceCosts1
2000000 USD
CY2019Q1 us-gaap Severance Costs1
SeveranceCosts1
300000 USD
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3400000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6200000 USD
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.007
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.225
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0230
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3162428 shares
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
344616 shares
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
24.51
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
102.51
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M
CY2019Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
200000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7200000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10700000 USD
CY2018Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
800000 shares
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1279900000 USD
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1305300000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1396300000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1369500000 USD
CY2019Q1 us-gaap Transfer Of Financial Assets Accounted For As Sales Cash Proceeds Received For Assets Derecognized Amount
TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount
1800000 USD
CY2019Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
103.89
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1200000 shares
CY2019Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1800000 shares
CY2019Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
800000 shares
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
103700000 USD
CY2019Q1 us-gaap Treasury Stock Value
TreasuryStockValue
172600000 USD
CY2018Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
47900000 USD
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
83100000 USD
CY2018Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
600000 USD
CY2019Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
600000 USD
CY2019Q1 us-gaap Variable Lease Cost
VariableLeaseCost
600000 USD
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75500000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75300000 shares
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73900000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74100000 shares
CY2019Q1 wst Contractwith Customer Asset Increase Decrease
ContractwithCustomerAssetIncreaseDecrease
2800000 USD
CY2018Q1 wst Developmentandlicensingincome
Developmentandlicensingincome
200000 USD
CY2019Q1 wst Developmentandlicensingincome
Developmentandlicensingincome
200000 USD
CY2019Q1 wst Increase Decreaseof Other Operating Incomeand Expense
IncreaseDecreaseofOtherOperatingIncomeandExpense
-2600000 USD
CY2018Q1 wst Other Income Expense
OtherIncomeExpense
-3100000 USD
CY2019Q1 wst Other Income Expense
OtherIncomeExpense
2300000 USD
CY2018Q1 wst Purchases And Royalty Payments From Equity Method Investees
PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
23100000 USD
CY2019Q1 wst Purchases And Royalty Payments From Equity Method Investees
PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
24600000 USD
CY2018Q1 wst Sales To Equity Method Investees
SalesToEquityMethodInvestees
2400000 USD
CY2019Q1 wst Sales To Equity Method Investees
SalesToEquityMethodInvestees
2200000 USD
CY2018Q1 wst Tax Cutsand Jobs Actof2017 Incomplete Accounting Changein Tax Rate Provisional Income Tax Expense
TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense
300000 USD

Files In Submission

Name View Source Status
0000105770-19-000020-index-headers.html Edgar Link pending
0000105770-19-000020-index.html Edgar Link pending
0000105770-19-000020.txt Edgar Link pending
0000105770-19-000020-xbrl.zip Edgar Link pending
ex1022019psuawardagreement.htm Edgar Link pending
ex1032019stockoptionawarda.htm Edgar Link pending
ex311q12019.htm Edgar Link pending
ex312q12019.htm Edgar Link pending
ex321q12019.htm Edgar Link pending
ex322q12019.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
psuaward1.jpg Edgar Link pending
psuaward3.gif Edgar Link pending
pswaward2.gif Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
stockoptionaward1.jpg Edgar Link pending
stockoptionaward2.gif Edgar Link pending
stockoptionaward3.gif Edgar Link pending
wst-20190331.xml Edgar Link completed
wst-20190331.xsd Edgar Link pending
wst-20190331_cal.xml Edgar Link unprocessable
wst-20190331_def.xml Edgar Link unprocessable
wst-20190331_lab.xml Edgar Link unprocessable
wst-20190331_pre.xml Edgar Link unprocessable
wst10q33119.htm Edgar Link pending